AIR-NET
Northern Ireland Clinical Research Facility
Principal Investigator/s: Dr Dermot Linden
Name of the Study: AIR-NET
Why is this Study important?
To improve outcomes in patients with bronchiectasis not due to cystic fibrosis, within the EMBARC international clinical research network.
What is the Research question/aim?:
AIR-NET is a multi-arm, adaptive platform trial designed to test the anti-inflammatory effects of multiple repurposed compounds in patients with bronchiectasis.
The primary objective is to evaluate the effect of a range of interventions compared to usual care on the activity of Neutrophil elastase in sputum.
What the Study involves:
Participants will be randomized to one of multiple potential interventions or usual care and treated for 28-days. Study duration for each patient is approximately 12 weeks.
Who can take part in the Study?
Patients with bronchiectasis not due to cystic fibrosis.
Contact Information:
Michelle Spence, Research Physiologist
Tel: 028095040342/ 02895041953
Location:
NI Clinical Research Facility,
U Floor, Belfast City Hospital,
Lisburn Road, Belfast, BT9 7AB
Tel:+44 (0)28 9504 0342
Email:NICRF@qub.ac.uk
